Cargando…

Analysis of Sex-Specific Prostanoid Production Using a Mouse Model of Selective Cyclooxygenase-2 Inhibition

BACKGROUND: Prostanoids are a family of lipid mediators formed from arachidonic acid by cyclooxygenase enzymes and serve as biomarkers of vascular function. Prostanoid production may be different in males and females indicating that different therapeutic approaches may be required during disease. OB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Upmacis, Rita K, Becker, Wendy L, Rattendi, Donna M, Bell, Raven S, Jordan, Kelsey D, Saniei, Shayan, Mejia, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749041/ https://www.ncbi.nlm.nih.gov/pubmed/36533270 http://dx.doi.org/10.1177/11772719221142151

Ejemplares similares

The role of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide and interleukin-1 stimulated enterocyte prostanoid formation.
por: Longo, W E, et al.
Publicado: (1998)

Significance of Pulmonary Endothelial Injury and the Role of Cyclooxygenase-2 and Prostanoid Signaling
por: Nickl, Rosa, et al.
Publicado: (2023)

The role of selective cyclooxygenase isoforms in human intestinal smooth muscle cell stimulated prostanoid formation and proliferation.
por: Longo, W E, et al.
Publicado: (1998)

Epigenetic Regulations of Inflammatory Cyclooxygenase-Derived Prostanoids: Molecular Basis and Pathophysiological Consequences
por: Harizi, Hedi
Publicado: (2015)

Mass Spectrometric Analysis of Oxidized Eicosapentaenoic Acid Sodium Salt
por: Jordan, Kelsey D, et al.
Publicado: (2013)

Purinergic Signaling Induces Cyclooxygenase-1-Dependent Prostanoid Synthesis in Microglia: Roles in the Outcome of Excitotoxic Brain Injury
por: Anrather, Josef, et al.
Publicado: (2011)

Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF-κB suppression
por: Rungseesantivanon, Sirada, et al.
Publicado: (2010)

Chronic Low-Level Lead Exposure Increases Mesenteric Vascular Reactivity: Role of Cyclooxygenase-2-Derived Prostanoids
por: Simões, Maylla Ronacher, et al.
Publicado: (2021)

Increased Cyclooxygenase-2-Derived Prostanoids Contributes to the Hyperreactivity to Noradrenaline in Mesenteric Resistance Arteries from Offspring of Diabetic Rats
por: Ramos-Alves, Fernanda E., et al.
Publicado: (2012)

Physiology and pathophysiology of prostanoid receptors
por: Narumiya, Shuh
Publicado: (2007)

Differential gene expression patterns in cyclooxygenase-1 and cyclooxygenase-2 deficient mouse brain
por: Toscano, Christopher D, et al.
Publicado: (2007)

Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E(2)
por: Herrerias, Aida, et al.
Publicado: (2009)

Prostanoid Receptors in the Human Vascular Wall
por: Norel, Xavier
Publicado: (2007)

Prostanoid Metabolites as Biomarkers in Human Disease
por: Idborg, Helena, et al.
Publicado: (2022)

The Link between Prostanoids and Cardiovascular Diseases
por: Beccacece, Livia, et al.
Publicado: (2023)

Prostanoid therapies in the management of pulmonary arterial hypertension
por: LeVarge, Barbara L
Publicado: (2015)

Effect of Prostanoids on Human Platelet Function: An Overview
por: Braune, Steffen, et al.
Publicado: (2020)

Complex Role for E‐Prostanoid 4 Receptors in Hypertension
por: Herrera, Marcela, et al.
Publicado: (2019)

Transitioning Between Prostanoid Therapies in Pulmonary Arterial Hypertension
por: Pan, Irene Z., et al.
Publicado: (2020)

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
por: Li, Wei, et al.
Publicado: (2011)

The Immunobiology of Prostanoid Receptor Signaling in Connecting Innate and Adaptive Immunity
por: Harizi, Hedi
Publicado: (2013)

Prostanoids and Resolution of Inflammation – Beyond the Lipid-Mediator Class Switch
por: Schmid, Tobias, et al.
Publicado: (2021)

Prostanoid Signaling in Cancers: Expression and Regulation Patterns of Enzymes and Receptors
por: Ershov, Pavel V., et al.
Publicado: (2022)

The role of thromboxane prostanoid receptor signaling in gastric ulcer healing
por: Yamane, Sakiko, et al.
Publicado: (2021)

Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing
por: Papa, Silvia, et al.
Publicado: (2023)

Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma
por: Seliger, Corinna, et al.
Publicado: (2016)

The affinity, intrinsic activity and selectivity of a structurally novel EP(2) receptor agonist at human prostanoid receptors
por: Coleman, R A, et al.
Publicado: (2019)

Crystal structure of bis[1-(2-hydroxyethyl)-2-methyl-5-nitro-1H-imidazole-κN (3)]silver(I) tetrafluoridoborate methanol monosolvate
por: Palmer, Joshua H., et al.
Publicado: (2015)

Crystal structure of di-μ-chlorido-bis[chloridobis(1,2-dimethyl-5-nitro-1H-imidazole-κN (3))copper(II)] acetonitrile disolvate
por: Quinlivan, Patrick J., et al.
Publicado: (2016)

EP4-mediated prostanoid signalling promotes oral cancer progression
por: Sapienza, Karen, et al.
Publicado: (2010)

Prostanoid Receptors Involved in Regulation of the Beating Rate of Neonatal Rat Cardiomyocytes
por: Mechiche, Hakima, et al.
Publicado: (2012)

Insights into the Prostanoid Pathway in the Ovary Development of the Penaeid Shrimp Penaeus monodon
por: Wimuttisuk, Wananit, et al.
Publicado: (2013)

E-type prostanoid receptor 4 (EP4) in disease and therapy
por: Konya, Viktoria, et al.
Publicado: (2013)

Contribution of prostanoid FP receptor and prostaglandins in transient inflammatory ocular hypertension
por: Yamagishi-Kimura, Reiko, et al.
Publicado: (2018)

Improved homology modeling of the human & rat EP(4) prostanoid receptors
por: Holt, Melissa C., et al.
Publicado: (2019)

Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
por: Queck, Alexander, et al.
Publicado: (2019)

Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003)

Cell‐Specific Actions of the Prostaglandin E‐Prostanoid Receptor 4 Attenuating Hypertension: A Dominant Role for Kidney Epithelial Cells Compared With Macrophages
por: Yang, Ting, et al.
Publicado: (2022)

The cyclooxygenases
por: Chandrasekharan, NV, et al.
Publicado: (2004)

Laropiprant Attenuates EP3 and TP Prostanoid Receptor-Mediated Thrombus Formation
por: Philipose, Sonia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hvs2ouv5450n6o7mlqa8dq8m1f